(Updated - July 30, 2025 5:44 AM EDT)

BTIG analyst Mark Massaro downgraded Neogenomics (NASDAQ: NEO) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE